Follow
George Jour
George Jour
Verified email at nyumc.org
Title
Cited by
Cited by
Year
Validation of the risk model: high-risk classification and tumor pattern of invasion predict outcome for patients with low-stage oral cavity squamous cell carcinoma
Y Li, S Bai, W Carroll, D Dayan, JC Dort, K Heller, G Jour, H Lau, ...
Head and neck pathology 7, 211-223, 2013
1932013
Association of initial viral load in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients with outcome and symptoms
KV Argyropoulos, A Serrano, J Hu, M Black, X Feng, G Shen, M Call, ...
The American journal of pathology 190 (9), 1881-1887, 2020
1922020
Autoimmune dermatologic toxicities from immune checkpoint blockade with anti‐PD‐1 antibody therapy: a report on bullous skin eruptions
G Jour, IC Glitza, RM Ellis, CA Torres‐Cabala, MT Tetzlaff, JY Li, ...
Journal of cutaneous pathology 43 (8), 688-696, 2016
1412016
Microbial signatures in the lower airways of mechanically ventilated COVID-19 patients associated with poor clinical outcome
I Sulaiman, M Chung, L Angel, JCJ Tsay, BG Wu, ST Yeung, ...
Nature microbiology 6 (10), 1245-1258, 2021
1172021
Using machine learning algorithms to predict immunotherapy response in patients with advanced melanoma
P Johannet, N Coudray, DM Donnelly, G Jour, I Illa-Bochaca, Y Xia, ...
Clinical Cancer Research 27 (1), 131-140, 2021
1122021
Renal neuroendocrine tumours: a clinicopathological study
BR Lane, F Chery, G Jour, L Sercia, C Magi‐Galluzzi, AC Novick, M Zhou
BJU international 100 (5), 1030-1035, 2007
1042007
Clinical genomic sequencing of pediatric and adult osteosarcoma reveals distinct molecular subsets with potentially targetable alterations
Y Suehara, D Alex, A Bowman, S Middha, A Zehir, D Chakravarty, L Wang, ...
Clinical Cancer Research 25 (21), 6346-6356, 2019
892019
Sequencing identifies multiple early introductions of SARS-CoV-2 to the New York City region
MT Maurano, S Ramaswami, P Zappile, D Dimartino, L Boytard, ...
Genome research 30 (12), 1781-1788, 2020
772020
Angiogenesis in melanoma: an update with a focus on current targeted therapies
G Jour, D Ivan, PP Aung
Journal of clinical pathology 69 (6), 472-483, 2016
742016
Renal neuroendocrine tumors
BR Lane, G Jour, M Zhou
Indian Journal of Urology 25 (2), 155-160, 2009
642009
Role of angiogenesis in melanoma progression: Update on key angiogenic mechanisms and other associated components
WC Cho, G Jour, PP Aung
Seminars in cancer biology 59, 175-186, 2019
612019
High amplification levels of MDM2 and CDK4 correlate with poor outcome in patients with dedifferentiated liposarcoma: A cytogenomic microarray analysis of 47 cases
RW Ricciotti, AJ Baraff, G Jour, MK Kyriss, Y Wu, Y Liu, SC Li, B Hoch, ...
Cancer genetics 218, 69-80, 2017
582017
Molecular profiling of soft tissue sarcomas using next-generation sequencing: a pilot study toward precision therapeutics
G Jour, JD Scarborough, RL Jones, E Loggers, SM Pollack, CC Pritchard, ...
Human pathology 45 (8), 1563-1571, 2014
542014
Melanoma-secreted amyloid beta suppresses neuroinflammation and promotes brain metastasis
K Kleffman, G Levinson, IVL Rose, LM Blumenberg, SAA Shadaloey, ...
Cancer discovery 12 (5), 1314-1335, 2022
452022
Analytical performance of lateral flow immunoassay for SARS-CoV-2 exposure screening on venous and capillary blood samples
MA Black, G Shen, X Feng, WFG Beltran, Y Feng, V Vasudevaraja, ...
Journal of immunological methods 489, 112909, 2021
452021
Prognostic relevance of Federation Nationale des Centres de Lutte Contre le Cancer grade and MDM2 amplification levels in dedifferentiated liposarcoma: a study of 50 cases
G Jour, A Gullet, M Liu, BL Hoch
Modern Pathology 28 (1), 37-47, 2015
452015
Cutaneous carcinosarcoma: further insights into its mutational landscape through massive parallel genome sequencing
A Paniz-Mondolfi, R Singh, G Jour, M Mahmoodi, AH Diwan, BA Barkoh, ...
Virchows Archiv 465, 339-350, 2014
432014
A deep learning approach for rapid mutational screening in melanoma
RH Kim, S Nomikou, N Coudray, G Jour, Z Dawood, R Hong, E Esteva, ...
BioRxiv, 610311, 2019
412019
Differential Expression of p16INK4A and Cyclin D1 in Benign and Malignant Salivary Gland Tumors: A Study of 44 Cases
G Jour, K West, V Ghali, D Shank, G Ephrem, BM Wenig
Head and neck pathology 7, 224-231, 2013
412013
PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrum
KT Alhalabi, D Stichel, P Sievers, H Peterziel, AC Sommerkamp, D Sturm, ...
Acta neuropathologica 142 (5), 841-857, 2021
402021
The system can't perform the operation now. Try again later.
Articles 1–20